Ursolic acid: A promising therapeutic agent for metabolic dysfunction-associated steatotic liver disease via inhibition of SPP1-induced Th17 cell differentiation: Editorial on "Ursolic acid targets secreted phosphoprotein 1to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease"

被引：1
|
作者：
Kim, So Jung [1 ]
Hyun, Jeongeun [1 ]
机构：
[1] Dankook Univ, Dept Nanobiomed Sci, Dandea Ro 119, Cheonan 31116, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2024年 / 30卷 / 04期
关键词：
Metabolic dysfunction-associated steatotic liver disease; Ursolic acid; Secreted phosphoprotein 1; Helper T 17; HEPATIC STEATOSIS; OSTEOPONTIN; PROTECTS; FIBROSIS;
D O I：
10.3350/cmh.2024.0412
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：6
相关论文
共 7 条
  • [1] Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease
    Zheng, Yiyuan
    Zhao, Lina
    Xiong, Zhekun
    Huang, Chaoyuan
    Yong, Qiuhong
    Fang, Dan
    Fu, Yugang
    Gu, Simin
    Chen, Chong
    Li, Jiacheng
    Zhu, Yingying
    Liu, Jing
    Liu, Fengbin
    Li, Yong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (03) : 449 - 467
  • [2] The role of SPP1 in MASLD pathogenesis: Therapeutic insights into ursolic acid's mechanisms of action: Correspondence to editorial on "Ursolic acid targets secreted phosphoprotein 1to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease "
    Zhen, Yiyuan
    Xion, Zhekun
    Zhao, Lina
    Huan, Chaouan
    Yon, Qiuhon
    Fan, Dan
    Liu, Fenbin
    Li', Yong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [3] Ursolic Acid Modulates Estrogen Conversion to Relieve Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease via HSD17B14
    Gu, Simin
    Zhang, Hui
    Xiong, Zhekun
    Chen, Chong
    Wang, Junmin
    Fang, Dan
    Zheng, Yiyuan
    Li, Yong
    Zheng, Yiyuan
    Li, Yong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2025, : 269 - 277
  • [4] Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease
    Kim, Hyun Young
    Rosenthal, Sara Brin
    Liu, Xiao
    Miciano, Charlene
    Hou, Xiaomeng
    Miller, Michael
    Buchanan, Justin
    Poirion, Olivier B.
    Chilin-Fuentes, Daisy
    Han, Cuijuan
    Housseini, Mojgan
    Weber, Raquel Carvalho-Gontijo
    Sakane, Sadatsugu
    Lee, Wonseok
    Zhao, Huayi
    Diggle, Karin
    Preissl, Sebastian
    Glass, Christopher K.
    Ren, Bing
    Wang, Allen
    Brenner, David A.
    Kisseleva, Tatiana
    JOURNAL OF HEPATOLOGY, 2025, 82 (05)
  • [5] Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two targets with one shot
    Kaya, Eda
    Syn, Wing-Kin
    Manka, Paul
    CURRENT OPINION IN GASTROENTEROLOGY, 2025, 41 (03) : 104 - 109
  • [6] BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice
    Xia, Beibei
    Yu, Rongfei
    Liu, Junxiong
    Liu, Dongmeng
    Li, Shasha
    Yang, Liu
    Liu, Nan
    Liang, Bosen
    Zeng, Jiajing
    Wei, Jinhua
    Lin, Guimiao
    TOXICOLOGY LETTERS, 2024, 391 : 100 - 110
  • [7] Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways
    Tamilmani, P.
    Uddandrao, V. V. Sathibabu
    Chandrasekaran, P.
    Saravanan, G.
    Naidu, Parim Brahma
    Sengottuvelu, S.
    Vadivukkarasi, S.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (10)
1